Explore FIGS stock in detail: latest price, earnings beat, technicals, analyst targets, valuation, and buy/hold outlook for healthcare apparel leader. Data as of March 2, 2026
Introduction
FIGS stock draws attention from investors eyeing healthcare apparel growth. The company designs and sells comfortable scrubs and related gear directly to medical pros online. Recent earnings beats amid a strong market boost interest now. Broader conditions like healthcare spending and e-commerce trends aid FIGS stock.
Latest Stock Price & Trend
FIGS stock closed at $15.40 on the last market session. It gained 18.1% in one day after Q4 results. Over five days, it rose sharply on earnings momentum. The one-month trend shows solid gains from pre-earnings levels. In three months, FIGS stock climbed with improving profitability. Six-month performance reflects recovery, up amid sector tailwinds. Year-to-date through early 2026, it advanced strongly post-2025 results. The 52-week high hit near $15.90 recently, low around $3.57 last year. This bullish trend signals growing investor confidence in growth. Everyday investors see opportunity in sustained upward moves.
Technical Analysis
Support levels sit near $13.61, recent lows where buyers stepped in. Resistance looms at $15.90, the new high buyers test. RSI at 49.28 shows neutral, not overbought or oversold—room to run. MACD at -0.13 hints mild sell pressure short-term. The 50-day moving average trends above the 200-day, no death cross. No golden cross yet, but bullish alignment builds. Volume surged on earnings, confirming interest. These indicators matter as they gauge momentum for entry points. Beginners use them to spot buy/sell signals safely.
Analyst Ratings & Price Targets
Twelve analysts rate FIGS stock mostly Hold. Breakdown: several Buys, Holds dominate, few Sells. Average target $10.53, high $17 from Keybanc, low $4.50. Recent upgrades include Keybanc to $17, Telsey to $15 on Feb 27, 2026. BTIG also positive post-earnings. Wall Street sees upside but tempers with competition risks. This mixed sentiment guides investors toward caution with growth potential.
Insider Activity
Recent insider selling noted, like Heather Hasson sale at $4.45 per share in June prior year. No major recent buys highlighted. Insiders hold 6.28%, institutions 92.82%. Trends show modest sales, no panic dumping. This suggests steady confidence, not aggressive accumulation. Investors watch for buying as a stronger vote.
Valuation Analysis
Trailing P/E stands high at 196.10, forward likely lower on growth. Price-to-sales reflects premium on $631.1M 2025 revenue. YoY revenue grew 13.6%, EPS improved to $0.10 Q4. Free cash flow hit $53.0M last year, solid. Low debt, strong cash with quick ratio 2.93, current 4.82. Compared to peers like broader retail, FIGS trades rich but justified by niche. FIGS stock appears fairly valued on earnings trajectory, not cheap but not bubbly.
Recent Earnings & Catalysts
Q4 2025 revenue $201.9M beat estimates by wide margin, up 33% YoY. EPS $0.10 topped forecasts. Full-year revenue $631.1M, up 13.6%, net income improved. Guidance: 10-12% revenue growth 2026, EBITDA margin 12.7-12.9%. Catalysts include active customers at 2.9M, up sharply. Earnings drove the 18% stock pop.
Bullish Case
Customer base expansion to 2.9M fuels revenue. Healthcare apparel demand stays firm. Direct-to-consumer model boosts margins to 69.9%. Guidance signals double-digit growth. Operational tweaks lift profitability.
Bearish Case
Competition from big retail erodes share. Growth may slow post-surge. Margin pressures if costs rise. Customer churn risk in economic dips. High P/E invites volatility.
Market Sentiment & Investor Psychology
Short interest around 10.19M shares, 6% of float. Options lean calls post-earnings. Institutions own 92.82%, steady. Retail piles in on momentum. Sentiment tilts optimistic on beats.
Short-Term Outlook
Technicals show bullish bias with volume support. Momentum from earnings persists. Watch resistance at $15.90. Expect volatility but upside bias next weeks.
Medium to Long-Term Outlook
Strong model in growing healthcare niche. Industry e-commerce rises. Financials healthy with cash flow. Competitive edge in scrubs. Long-term investors should hold, watch for pullbacks to accumulate.
FAQ
Is FIGS stock a buy right now? Hold for now; recent beats support but high valuation warrants caution.
What is the price target for FIGS stock? Average $10.53, high $17, low $4.50 from analysts.
What are major risks for FIGS stock? Competition, slowing growth, high P/E.
FIGS stock forecast? 10-12% revenue growth guided for 2026.
What is FIGS earnings? Q4 $201.9M revenue, $0.10 EPS beat.
Suggestions
- Compare with Opendoor stock analysis
- See our Microsoft stock forecast
- Read our tech sector valuation breakdown
Final Balanced Conclusion
Hold FIGS stock. Earnings strength and guidance offset valuation risks in competitive space. Balanced view favors patience.
Disclaimer: This article is for informational purposes only and not financial advice.